Boards & Committees - I2C2
INTERNATIONAL & INTER-SOCIETY COORDINATION COMMITTEE (I2C2)
COMMITTEE LEADERSHIP:CORE LEADERS:
April 2015, Nice, FRANCE (date/time TBA)
The I2C2 will take a leadership role in reacting to important international developments of interest to the membership of ISHLT. The group will work closely with the Board of Directors and Councils to develop timely and appropriate responses and policies for the benefit of the Society and the patients we serve.
It is a pivotal role of I2C2 to develop formal relationships with other Societies where mutual benefits may be attained, membership shared, and common goals exist. There are many areas of benefit to ISHLT members where collaborative working can take place on a formal basis and meaningful liaisons developed. This role will also include establishing external representation for ISHLT on the international stage and ensuring that we exert influence in the interests of ISHLT's wider aims. With the permission of the Board, the I2C2 will be a policy-making group where relevant.
For more information, visit I2C2--Bringing ISHLT to the World
Newcastle Upon Tyne, UNITED KINGDOM
email@example.comBio coming soon...
University of Alberta
Edmonton, Alberta, CANADA
firstname.lastname@example.orgDr. Lori West is the Director of Heart Transplantation Research and a Professor of Pediatrics, Surgery and Immunology at the University of Alberta - one of the largest heart transplant programs in the world. Dr. West completed her pediatric residency at Harbor-UCLA Medical Center. She trained in pediatric cardiology at the Hospital for Sick Children, Toronto, and subsequently in pediatric transplant cardiology at Pittsburgh Children's Hospital, Loma Linda University Medical Center and Columbia-Presbyterian Children's Hospital. She obtained her PhD for specialized training in transplant immunology research at Oxford University and works in the role of a clinician-scientist.
Hospital Universitario A Coruña
La Coruña, SPAIN
34-981-178-304Marisa.Crespo.Leiro@sergas.esMaria G (Marisa) Crespo-Leiro, MD, PhD, FESC, is the Medical Director of the Advanced Heart Failure Transplant Unit at the Hospital Universitario A Coruña, La Coruña, Spain. She obtained her MD degree at the University of Santiago de Compostela, her specialization in cardiology at Clinica Puerta de Hierro in Madrid and her PhD from Universidad Autónoma de Madrid. Since 1993 she has been working in the Heart Division at the Hospital Universitario A Coruña (formerly the Hospital Universitario Juan Canalejo) in La Coruña, where she is also Associate Professor of Medicine. Her main fields of research interest are heart failure and heart transplantation.
St. Vincent's Hospital
email@example.comProfessor Glanville trained in Sydney, Brompton Hospital, London and Stanford University, California. Currently working as a specialist in Lung Transplantation at St. Vincent's Hospital Sydney, he is actively involved with international trials into new immunosuppressive and anti-viral agents. He is Global Principal Investigator for the European and Australian Investigators in Lung Transplantation CeMyLungs trial, and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. He has authored over 140 publications including approaches to antibody mediated rejection, bronchoscopic surveillance, RSV, CMV, Chlamydia and mycobacteria. He is the senior author of the International Guidelines for Lung Transplantation, foundation director of Outcomes Australia and a foundation member of ShareLife Australia.
University of Wisconsin
Madison, Wisconsin, USA
firstname.lastname@example.orgMaryl R. Johnson, MD, received her medical degree from the University of Iowa College of Medicine where she also completed postgraduate training in Internal Medicine and Cardiovascular Diseases. She joined the faculty at Iowa and was instrumental in the establishment of a cardiac transplant program, serving as the Medical Director of Cardiac Transplantation from 1984-1988. Her subsequent career has been entirely devoted to the care of patients with heart failure and following cardiac transplantation. She served as the Associate Medical Director of the Cardiac Transplant Program at Loyola University Medical Center from 1988-1994, Associate Medical Director of the Rush Heart Failure and Cardiac Transplant Program from 1994-1997, and Medical Director, Heart Failure and Transplantation at Northwestern Memorial Hospital from 1998-2002. She moved to the University of Wisconsin as Medical Director of Heart Failure and Transplantation and Professor of Medicine in July 2002. Dr. Johnson's clinical interests are in the care of patients with severe congestive heart failure, including the use of mechanical circulatory support devices and cardiac transplantation. She has a particular interest in the treatment and outcome of congestive heart failure in women. Her research interests include the use of mechanical assistance in patients with severe heart failure and the coronary artery disease which develops in cardiac transplant recipients. She has also been an investigator in many of the multicenter trials evaluating new agents for the medical treatment of heart failure.
Sheba Medical Center
Leviev Heart Center
Tel Hashomer, ISRAEL
email@example.comProf. Jacob Lavee is the Director of the Heart Transplantation Unit and Deputy Director of the Department of Cardiac Surgery at the Leviev Heart Center of the Sheba Medical Center which is affiliated to the Tel Aviv University Faculty of Medicine. He received his M.D. cum laude degree from the Tel Aviv University Faculty of Medicine in Israel and was subsequently trained in cardiothoracic surgery at the Sheba Medical Center. He later trained in heart and lung transplantation at the University of Pittsburgh Medical Center and in 1991 founded the Heart Transplantation Unit at the Sheba Medical Center which since has become Israel’s largest unit of its kind. Since 1997 he has developed an active ventricular assist device program and in 2001 implanted the first-in-man HeartMate II LVAD. He is the past Chairman of the Israel Society Of Cardiothoracic Surgery, past President of the Israel Transplantation Society and currently serves as Chairman of the Heart and Lung Transplantation committee of Israel’s National Transplant Center and Israel’s representative in the Declaration of Istanbul Custodian Group.
firstname.lastname@example.orgA/Prof Bronwyn Levvey is the clinical lung transplant nursing team leader of the Lung Transplant Service at The Alfred Hospital, Melbourne Australia. Appointed as Adjunct Clinical Associate Professor in the Department of Medicine, Faculty of Nursing & Health Sciences at Monash University (Melbourne) in 2008 in recognition of her strong commitment to transplantation nursing education and clinical research, she has authored or co-authored more than 60 peer review scientific publications. Since 2005, a major focus of A/Prof Levvey’s clinical research has been the successful evolution and development of Category III DCD Lung donation and transplantation in Australia. An ISHLT member since 2000, she is the current National President of the Transplant Nurses Association (TNA) of Australia, a member of TTS and the Transplantation Society of Australia & New Zealand (TSANZ), and is a member of several Australian government organ donation and transplantation advisory boards.
Toronto General Hospital
Toronto, Ontario, CANADA
email@example.comDr. Heather Ross is the Director of Heart Failure and Transplantation, Deputy Director for the MultiOrgan Transplant Program, and an Associate Professor of Medicine at the University Health Network, University of Toronto, Canada. Dr. Ross completed her Internal Medicine residency at the University of British Columbia in Vancouver, Canada. She trained in cardiology at Dalhousie, Nova Scotia, Canada, and subsequently in cardiac transplant at Stanford University, Palo Alto California. She completed her Masters in Bioethics at the University of Toronto.
University of Utah
Salt Lake City, Utah, USA
firstname.lastname@example.orgJosef Stehlik, MD, MPH is an Associate Professor of Medicine at the University of Utah School of Medicine. Dr. Stehlik received his medical degree from Charles University in Prague and Masters in Public Health degree from Harvard School of Public Health. He completed his training in Internal Medicine and in Cardiovascular Diseases at Allegheny General Hospital, MCP*Hahnemann University and advanced training in Heart Failure and Transplantation at the Cleveland Clinic. Dr. Stehlik has been on faculty at the University of Utah since 2004 and serves as Medical Director of the Heart Transplant Program at the University of Utah Hospital and the Salt Lake City Veterans Affairs Medical Center. He has been active in clinical work, education and research in the areas of advanced heart failure, heart transplantation and mechanical circulatory support.
University Hospital Gasthuisberg
email@example.comG.M. Verleden obtained his MD degree in 1983 and his PhD in 1993, after being trained in internal medicine, pulmonary medicine and intensive care medicine. He is currently full professor of Pulmonary Medicine at the Katholieke Universiteit Leuven and at the University Hospital Gasthuisberg in Belgium. He is the medical director of the Leuven Lung Transplant programme, which was initiated in 1991. His research interests are primarily in the area of inflammation of the airways with particular interest in the role of the airway smooth muscle and the neutrophils in chronic rejection after lung transplantation and the potential role of neo-macrolides to treat this condition.
Loyola University Medical Center
Maywood, Illinois, USA
firstname.lastname@example.orgChristopher Wigfield, MD, MD, FRCS(C/Th), is Assistant Professor of Thoracic and Cardiovascular Surgery at Loyola University Medical Center in Maywood, Illinois. Dr. Wigfield received his clinical MD at Freie Universitaet Berlin, Germany and an additional Medical Sciences MD from the University of Newcastle upon Tyne, United Kingdom. He completed residencies in General Surgery at Royal Berkshire Hospital and at Freeman Hospital in the UK and went on to complete a fellowship in Cardiothoracic Surgery and Cardiopulmonary Transplantation at the Cardiothoracic Centre in Newcastle upon Tyne, UK. He also completed a Cardiothoracic Surgery fellowship at the University of Wisconsin Hospitals and Clinics in Madison, Wisconsin, USA. Dr. Wigfield's clinical and research interests are in thoracic surgery, lung transplantation, robotic assisted surgery and minimally invasive thoracic surgery. He has a dedicated educational portfolio.COUNCIL WORKFORCE LEADERS:
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA
215-762-5080Howard.Eisen@DrexelMed.eduDr. Eisen obtained his MD from the University of Pennsylvania (UPenn) School of Medicine in 1981 where he was elected to Alpha Omega Alpha. He completed his internal medicine residency at the Hospital of UPenn (1981-1984), followed by a fellowship in cardiovascular medicine at Washington Univ in St. Louis and Barnes Hospital (1984-87) where he received training in the management of cardiac transplant recipients. He subsequently was on the faculty of UPenn School of Medicine and Temple Univ before joining the Drexel Univ College of Medicine and Hahnemann Univ Hospital as Chief of the Division of Cardiology in 2005. Dr. Eisen has been funded by the NIH to study microchimerism and cell adhesion molecule expression in cardiac transplant rejection and has played an important role in the investigation of gene expression profiling in cardiac transplantation. Dr. Eisen is board certified in Internal Medicine, Cardiovascular Diseases and Advanced Heart Failure and Transplant Cardiology by the American Board of Internal Medicine.
Texas Heart Institute
Houston, Texas, USA
832-355-9805DMeyers@texasheart.orgDeborah Meyers, MD is the Medical Director of Heart Failure Programs at Texas Heart Institute and St. Luke’s Episcopal Hospital in Houston, Texas. She is board certified in general cardiology and in advanced heart failure and transplantation. Dr. Meyers received her medical degree from the University of California, San Francisco School of Medicine where she also began her Internal Medicine residency. She completed her Cardiology Fellowship at Barnes-Jewish Hospital at Washington University in St. Louis. Dr. Meyers then traveled to Brisbane, Australia where she completed a post-graduate specialist training program at the University of Queensland, was awarded Fellowship in the Royal Australasian College of Physicians, and completed a fellowship in Heart Failure and Transplantation. In Australia, Dr. Meyers served as the Clinical Director of the Queensland Heart Failure & Transplantation Program and directed the Multidisciplinary Heart Failure Clinic at the Prince Charles Hospital in Chermside, Queensland. In 2008, she and her family returned to the United States. She continues to pursue her special interests in care delivery models, patient centered practice, medical decision making, the role of palliative services in heart failure, chronic disease management, and the relationship between physical activity and heart failure.
Sentara Norfolk Transplant Center/EVMS
Norfolk, Virginia, USA
email@example.comMartha Mooney, MD, is an Associate Professor at Eastern Virginia Medical School (EVMS) in Norfolk, Virginia. Dr. Mooney received her medical education at EVMS and a graduate degree in Biochemical Genetics from Old Dominion University in Norfolk. She completed her residency in Internal Medicine at Eastern Virginia Graduate School of Medicine and subsequently completed a fellowship in Infectious Disease, Research and Clinical, at the Medical College of Virginia in Richmond, Virginia.
University of Michigan Cardiovascular
Ann Arbor, Michigan, USA
firstname.lastname@example.orgBio coming soon...
University of Minnesota Medical Center-Fairview
Minneapolis, Minnesota, USA
email@example.comDr. Michael Petty is a Cardiothoracic Clinical Nurse Specialist at the University of Minnesota Medical Center, Fairview. He received his nursing degree from the University of Minnesota-Twin Cities in 1996 and earned his PhD at the University of Minnesota School of Nursing in 2010. He began his career as a staff nurse in the Surgical ICU at the University of Minnesota Hospital and Clinic, and has held a variety of clinical, administrative, and industry roles in the subsequent years. Much of his focus and interest during that time has been in the care of patients with cardiovascular disorders requiring medical, surgical, and transplant interventions.
Hospital for Sick Children
Toronto, Ontario, CANADA
firstname.lastname@example.orgAnne Dipchand, MD FRCPC, is Head of the Cardiac Transplant Program and a Staff Cardiologist at the Hospital for Sick Children in Toronto. She is also an Associate Professor of Pediatrics with the University of Toronto.
Senior Pharmacist - Cardiology
+613 9076 email@example.comRochelle Gellatly, PharmD is a Senior Pharmacist in Cardiology, specialising in advanced heart failure, mechanical circulatory support and heart transplantation. Rochelle also holds a senior adjunct appointment in post-graduate studies at the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University (Melbourne). Rochelle commenced her career in heart failure and transplantation at St. Paul's Hospital in Vancouver, Canada before moving to Australia. Her clinical practice interests include ventricular assist devices, immunosuppression and cardiovascular drug therapy.
Inova Fairfax Hospital
Falls Church, VA, USA
703-776-2256Oksana.Shlobin@inova.orgOksana A. Shlobin, MD, FCCP, is a co-director of the Inova Pulmonary Hypertension Program and an assistant director of Inova Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital, Falls Church, VA. She is an Associate Clinical Professor of Medicine at Georgetown University School of Medicine and Assistant Clinical Professor of Medicine at Virginia Commonwealth University School of Medicine. Dr. Shlobin received her medical degree from Georgetown University School of Medicine in Washington, DC. She completed her internship and residency in internal medicine at Harvard’s Beth Israel Deaconess Medical Center in Boston. Dr. Shlobin completed her fellowship in pulmonary and critical care medicine at Johns Hopkins University Hospital in Baltimore, MD. She is board certified in pulmonary medicine and critical care medicine. Dr. Shlobin is co-author of multiple publications, including original research manuscripts, abstracts and book chapters. Her research interests include pulmonary hypertension and interstitial lung diseases. She is a member of several professional medical associations, including the ISHLT, ATS, ACCP and the AOA.
Toronto General Hospital
Toronto, Ontario, CANADA
firstname.lastname@example.orgLianne Singer, MD, FRCPC is Medical Director of the Toronto Lung Transplant Program at the University Health Network in Toronto, Ontario, Canada. She is also Associate Professor in the Department of Medicine at the University of Toronto. She completed medical school, Internal Medicine and Respirology training at the University of Toronto. She went on to do a Lung and Heart-Lung Transplantation Fellowship at Stanford University, and advanced training in clinical research at the University of California, San Francisco. Dr. Singer's research interests arise directly from her clinical focus in lung transplantation and include health-related quality of life assessment in advanced lung disease and lung transplantation, telemedicine in lung transplantation, and clinical trials. GLOBAL AMBASSADORS:
Hospital General Plaza de La Salud
HGU Gregorio Marañon
Santo Domingo, DOMINICAN REPUBLIC
National Research Cardiac Surgery Center